Ocular features in neurosarcoidosis

Ocular Immunology and Inflammation

Volumn 17, Issue 3, 2009, Pages 170-178

  Menezo, Victor ^a   Lobo, Aires ^a   Yeo, Tun Kuan ^a   Du Bois, Roland M ^b   Lightman, Susan ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Anterior uveitis; Neurosarcoidosis; Non caseating granuloma; Peripheral neuropathy; Retinal vasculitis

Indexed keywords

ABDUCENS NERVE DISEASE; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CRANIAL NEUROPATHY; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; EYE BIOPSY; EYE INFLAMMATION; FACIAL NERVE PARALYSIS; FEMALE; HUMAN; HYPOPHYSIS DISEASE; INCIDENCE; IRIDOCYCLITIS; LUMBAR PUNCTURE; MALE; MEDICAL RECORD REVIEW; MOTONEURON; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; OPTIC NERVE DISEASE; PERIPHERAL NEUROPATHY; RETROSPECTIVE STUDY; SARCOIDOSIS; SPINAL CORD DISEASE; SYMPTOMATOLOGY; TRIGEMINAL NERVE DISEASE; TRIGEMINUS NEURALGIA; VAGUS NERVE DISEASE; VESTIBULAR NERVE;

ADULT; AGED; FEMALE; GRANULOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; RETINAL VASCULITIS; RETROSPECTIVE STUDIES; SARCOIDOSIS; UVEITIS, ANTERIOR;

EID: 68849111616     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940802687812     Document Type: Article

References (54)

1. Hosoda, Y, Yamaguchi, M, Hiraga, Y. Global epidemiology of sarcoidosis: what story do prevalence and incidence tell us?. Clin Chest Med. 1997;18:681-694.
2. Tozman, EC. Sarcoidosis: clinical manifestations, epidemiology, therapy, and pathophysiology. Curr Opin Rheumatol. 1991;3:155-159.
3. Rothova, A, Alberts, C, Glasius, E, et al. Risk factors for ocular sarcoidosis. Doc Ophthalmol. 1989;72:287-296.
4. Obenauf, CD, Shaw, HE, Sydnor, CF, et al. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978;86:648-655.
5. Hoitsma, E, Faber, CG, Drent, M, et al. Neurosarcoidosis: a clinical dilemma. Lancet Neurol. 2004;3:397-407.
6. Delaney, P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med. 1977;87:336-345.
7. Stern, BJ, Krumholz, A, Johns, C, et al. Sarcoidosis and its neurological manifestations. Arch Neurol. 1985;42:909-917.
8. Manz, HJ. Pathobiology of neurosarcoidosis and clinicopathologic correlation. Can J Neurol Sci. 1983;10:50-55.
9. Turner, RG, James, DG, Friedmann, AI, et al. Neuro-ophthalmic sarcoidosis. Br J Ophthalmol. 1975;59:657-663.
10. Towler, HM, Lightman, S. Symptomatic intraocular inflammation in multiple sclerosis. Clin Experiment Ophthalmol. 2000;28:97-102.
11. Zajicek, JP, Scolding, NJ, Foster, O, et al. Central nervous system sarcoidosis-diagnosis and management. QJM. 1999;92:103-117.
12. Kadakia, JK, Collette, PM, Sharma, OP. Role of magnetic resonance imaging in neurosarcoidosis. Sarcoidosis. 1993;10:98-99.
13. Jabs, DA, Johns, CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol. 1986;102:297-301.
14. Frohman, LP, Guirgis, M, Turbin, RE, et al. Sarcoidosis of the anterior visual pathway: 24 new cases. J Neuroophthalmol. 2003;23(3):190-197.
15. Agbogu, BN, Stern, BJ, Sewell, C, et al. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol. 1995;52:875-879.
16. Chapelon, C, Ziza, JM, Piette, JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore). 1990;69:261-276.
17. Baughman, RP, Teirstein, AS, Judson, MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885-1889.
18. Karma, A, Huhti, E, Poukkula, A. Course and outcome of ocular sarcoidosis. Am J Ophthalmol. 1988;106:467-472.
19. Caplan, L, Corbett, J, Goodwin, J, et al. Neuro-ophthalmologic signs in the angiitic form of neurosarcoidosis. Neurology. 1983;33:1130-1135.
20. Milman, N, Selroos, O. Pulmonary sarcoidosis in the Nordic countries 1950-1982: epidemiology and clinical picture. Sarcoidosis. 1990;7:50-57.
21. Khalatbari, D, Stinnett, S, McCallum, RM, et al. Demographicrelated variations in posterior segment ocular sarcoidosis. Ophthalmology. 2004;111:357-362.
22. Evans, M, Sharma, O, LaBree, L, et al. Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology. 2007;114:325-333.
23. Brinkman, CJ, Rothova, A. Fundus pathology in neurosarcoidosis. Int Ophthalmol. 1993;17:23-26.
24. Spalton, DJ, Sanders, MD. Fundus changes in histologically confirmed sarcoidosis. Br J Ophthalmol. 1981;65:348-358.
25. Lim, WK, Ursea, R, Rao, K, et al. Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome. Am J Ophthalmol. 2005;139:562-563.
26. Biousse, V, Trichet, C, Bloch-Michel, E, et al. Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology. 1999;52:179-181.
27. Beck, AD, Newman, NJ, Grossniklaus, HE, et al. Optic nerve enlargement and chronic visual loss. Surv Ophthalmol. 1994;38:555-566.
28. Silver, MR, Messner, LV. Sarcoidosis and its ocular manifestations. J Am Optom Assoc. 1994;65:321-327.
29. Constantino, T, Digre, K, Zimmerman, P. Neuro-ophthalmic complications of sarcoidosis. Semin Neurol. 2000;20:123-137.
30. Brindeau, C, Glacet-Bernard, A, Roualdes, B, et al. [Sarcoid optic neuropathy]. J Fr Ophtalmol. 1999;22:1072-1075.
31. Pelton, RW, Lee, AG, Orengo-Nania, SD, et al. Bilateral optic disk edema caused by sarcoidosis mimicking pseudotumor cerebri. Am J Ophthalmol. 1999;127:229-230.
32. Wiederholt, WC, Siekert, RG. Neurological manifestations of sarcoidosis. Neurology. 1965;15:1147-1154.
33. Bastiaensen, LA, Verpalen, MC, Pijpers, PM, et al. Conjunctival sarcoidosis. Doc Ophthalmol. 1985;59:5-9.
34. Leavitt, JA, Campbell, RJ. Cost-effectiveness in the diagnosis of sarcoidosis: the conjunctival biopsy. Eye. 1998;12 (Pt 6):959-962.
35. Spaide, RF, Ward, DL. Conjunctival biopsy in the diagnosis of sarcoidosis. Br J Ophthalmol. 1990;74:469-471.
36. Kaiser, PK, Lowder, CY, Sullivan, P, et al. Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol. 2002;133:499-505.
37. Kosmorsky, GS, Meisler, DM, Rice, TW, et al. Chest computed tomography and mediastinoscopy in the diagnosis of sarcoidosis-associated uveitis. Am J Ophthalmol. 1998;126:132-134.
38. Trojano, M, Paolicelli, D. The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes. Neurol Sci. 2001;22(Suppl 2):S98-S102.
39. Christoforidis, GA, Spickler, EM, Recio, MV, et al. MR of CNS sarcoidosis: correlation of imaging featuresto clinical symptoms and response to treatment. AJNR Am J Neuroradiol. 1999;20:655-669.
40. Bakshi, R, Miletich, RS, Kinkel, PR, et al. High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging. 1998;8:228-234.
41. Blake, P, Johnson, B, VanMeter, JW. Positron emission tomography (PET) and single photon emission computed tomography (SPECT): clinical applications. J Neuroophthalmol. 2003;23:34-41.
42. Dubey, N, Miletich, RS, Wasay, M, et al. Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis. J Neurol Sci. 2002;205:77-81.
43. Derache, N, Marie, RM, Constans, JM, et al. Reduced thalamic and cerebellar rest metabolism in relapsing-remitting multiple sclerosis, a positron emission tomography study: correlations to lesion load. J Neurol Sci. 2006;245:103-109.
44. Tahmoush, AJ, Amir, MS, Connor, WW, et al. CSF-ACE activity in probable CNS neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:191-197.
45. Chan Seem, CP, Norfolk, G, & Spokes, EG. CSF angiotensin-converting enzyme in neurosarcoidosis. Lancet. 1985;1(8426): 456-457.
46. Oksanen, V, Fyhrquist, F, Gronhagen-Riska, C, et al. CSF angiotensin-converting enzyme in neurosarcoidosis. Lancet. 1985;1(8436):1050-1051.
47. Oksanen, V. New cerebrospinal fluid, neurophysiological and neuroradiological examinations in the diagnosis and follow-up of neurosarcoidosis. Sarcoidosis. 1987;4:105-110.
48. Dale, JC, O'Brien, JF. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Mayo Clin Proc. 1999;74:535.
49. Borucki, SJ, Nguyen, BV, Ladoulis, CT, et al. Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis. Arch Neurol. 1989;46:270-273.
50. Christenson, RH, Behlmer, P, Howard JF Jr, et al. Interpretation of cerebrospinal fluid protein assays in various neurologic diseases. Clin Chem. 1983;29:1028-1030.
51. Scott, TF, Seay, AR, Goust, JM. Pattern and concentration of IgG in cerebrospinal fluid in neurosarcoidosis. Neurology. 1989;39:1637-1639.
52. Siltzbach, LE. The Kveim test in sarcoidosis: a study of 750 patients. JAMA. 1961;178:476-482.
53. Steuer, H, Jaworski, A, Elger, B, et al. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Invest Ophthalmol Vis Sci. 2005;46:1047-1053.
54. Birch, MK, Barbosa, S, Blumhardt, LD, et al. Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis. Arch Ophthalmol. 1996;114:34-39.